Skip to main content
Clinical Trials/NCT00938548
NCT00938548CompletedPhase 4

Perioperative Administration of Pregabalin for Pain After Mastectomy

Severance Hospital1 site in 1 country70 target enrollmentStarted: June 2009Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
70
Locations
1
Primary Endpoint
Pain Scores (Verbal Numerical Rating Scale;VNRS) During Postoperative Hours.

Study Overview

Brief Summary

The investigators hypothesize that pregabalin will decrease post-operative pain scores and analgesic use following total mastectomy compared to placebo. The primary outcome will be acute postoperative pain, measured by a verbal numerical rating score (VNRS) and total analgesic consumption during postoperative 48 hours. The secondary outcome will be VNRS at 1 week and 1 month after operation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
21 Years to 69 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • American Society of Anesthesia physical status class I & II
  • Age > 20 and < 70 years
  • Robot- assisted endoscopic thyroidectomy

Exclusion Criteria

  • Known or suspected allergy, sensitivity, or contraindication to pregabalin or any of the standardized medications
  • Body mass index ≥ 40 kg/m2
  • History of seizure disorder
  • Current therapy with pregabalin, gabapentin, or any opioid
  • Any other physical or psychiatric condition which may impair their ability to cooperate with post-operative study data collection
  • Insulin-dependent diabetes mellitus
  • Renal insufficiency (estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2)

Arms & Interventions

Placebo

Placebo Comparator

Patients receive oral Placebo 1 hour prior to surgery, and 12 hours later

Intervention: Vitamin Complex (placebo) (Drug)

Pregabalin

Experimental

Patients receive oral pregabalin 1 hour prior to surgery, and 12 hours later

Intervention: Pregabalin (Drug)

Outcomes

Primary Outcomes

Pain Scores (Verbal Numerical Rating Scale;VNRS) During Postoperative Hours.

Time Frame: 1, 6, 24, 48 hour

Pain was evaluated using an 11-point verbal numerical rating scale (VNRS). Patients were instructed preoperatively to express their pain on the 0-10 VNRS, where 0 represents no pain at all and 10 represents the worst pain imaginable.

Number of Participants With the Indicated Side Effects - Nausea & Vomiting, Sedation, Headache, Dizziness Etc.

Time Frame: 1, 6, 24, 48 hour

Nausea and vomiting was graded on a four-point scale, where 0 = no nausea, 1 = mild nausea, 2 = severe nausea requiring antiemetics, and 3 = retching and/ or vomiting. Grades 3 and 4 were grouped together as postoperative nausea and vomiting (PONV) and rescue anti-emetic, metoclopramide 10 mg i.v. was given.

Secondary Outcomes

  • Pain Scores (VNRS) at 1 Week and 1 Month After Operation(1 week, 1 month)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials